Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T46929
(Former ID: TTDR01292)
|
|||||
Target Name |
Eukaryotic translation initiation factor 5A-1 (EIF5A)
|
|||||
Synonyms |
eIF-5A1; eIF-5A-1; eIF-5A; eIF-4D; Rev-binding factor; Eukaryotic initiation factor 5A isoform 1
Click to Show/Hide
|
|||||
Gene Name |
EIF5A
|
|||||
Target Type |
Literature-reported target
|
[1] | ||||
Function |
A GTPase-activating protein, which helps the large ribosomal subunit associate with the small subunit. Involved in the initiation phase of eukaryotic translation. Stabilize the formation of ribosomal preinitiation complexes around the start codon and are an important input for post-transcription gene regulation. Helps with elongation and also plays a role in termination.
Click to Show/Hide
|
|||||
UniProt ID | ||||||
Sequence |
MADDLDFETGDAGASATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVG
IDIFTGKKYEDICPSTHNMDVPNIKRNDFQLIGIQDGYLSLLQDSGEVREDLRLPEGDLG KEIEQKYDCGEEILITVLSAMTEEAAVAIKAMAK Click to Show/Hide
|
|||||
3D Structure | Click to Show 3D Structure of This Target | AlphaFold |
Cell-based Target Expression Variations | Top | |||||
---|---|---|---|---|---|---|
Cell-based Target Expression Variations |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: N(6)-(4-Amino-2-hydroxybutyl)-L-lysine | Ligand Info | |||||
Structure Description | Crystal structure of RanGTP-Exportin 4-eIF5A complex | PDB:5DLQ | ||||
Method | X-ray diffraction | Resolution | 3.20 Å | Mutation | Yes | [2] |
PDB Sequence |
SATFPMQCSA
24 LRKNGFVVLK34 GRPCKIVEMS44 TSKTGHGHAK55 VHLVGIDIFT65 GKKYEDICPS 75 THNMDVPNIK85 RNDFQLIGIQ95 DGYLSLLQDS105 GEVREDLRLP115 EGDLGKEIEQ 125 KYDCGEEILI135 TVLSAMTEEA145 AVAIKAM
|
|||||
|
||||||
Click to View More Binding Site Information of This Target with Different Ligands |
Different Human System Profiles of Target | Top |
---|---|
Human Similarity Proteins
of target is determined by comparing the sequence similarity of all human proteins with the target based on BLAST. The similarity proteins for a target are defined as the proteins with E-value < 0.005 and outside the protein families of the target.
A target that has fewer human similarity proteins outside its family is commonly regarded to possess a greater capacity to avoid undesired interactions and thus increase the possibility of finding successful drugs
(Brief Bioinform, 21: 649-662, 2020).
Human Tissue Distribution
of target is determined from a proteomics study that quantified more than 12,000 genes across 32 normal human tissues. Tissue Specificity (TS) score was used to define the enrichment of target across tissues.
The distribution of targets among different tissues or organs need to be taken into consideration when assessing the target druggability, as it is generally accepted that the wider the target distribution, the greater the concern over potential adverse effects
(Nat Rev Drug Discov, 20: 64-81, 2021).
Biological Network Descriptors
of target is determined based on a human protein-protein interactions (PPI) network consisting of 9,309 proteins and 52,713 PPIs, which were with a high confidence score of ≥ 0.95 collected from STRING database.
The network properties of targets based on protein-protein interactions (PPIs) have been widely adopted for the assessment of target’s druggability. Proteins with high node degree tend to have a high impact on network function through multiple interactions, while proteins with high betweenness centrality are regarded to be central for communication in interaction networks and regulate the flow of signaling information
(Front Pharmacol, 9, 1245, 2018;
Curr Opin Struct Biol. 44:134-142, 2017).
Human Similarity Proteins
Human Tissue Distribution
Biological Network Descriptors
|
There is no similarity protein (E value < 0.005) for this target
|
Note:
If a protein has TS (tissue specficity) scores at least in one tissue >= 2.5, this protein is called tissue-enriched (including tissue-enriched-but-not-specific and tissue-specific). In the plots, the vertical lines are at thresholds 2.5 and 4.
|
Degree | 3 | Degree centrality | 3.22E-04 | Betweenness centrality | 6.07E-04 |
---|---|---|---|---|---|
Closeness centrality | 1.86E-01 | Radiality | 1.31E+01 | Clustering coefficient | 3.33E-01 |
Neighborhood connectivity | 3.53E+01 | Topological coefficient | 3.43E-01 | Eccentricity | 13 |
Download | Click to Download the Full PPI Network of This Target | ||||
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Hypusine: a new target for therapeutic intervention in diabetic inflammation. Discov Med. 2010 Jul;10(50):18-23. | |||||
REF 2 | Structure of the exportin Xpo4 in complex with RanGTP and the hypusine-containing translation factor eIF5A. Nat Commun. 2016 Jun 16;7:11952. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.